However, variable effects of MEF2C expression levels on BC patient survival as a function of disease time, race, and type of breast cancer, with the worst prognosis corresponding to Luminal BC with high MEF2C, are presented in the UALCAN database (http://ualcan.path.uab.edu; accessed in 24 January 2021). Here, MEF2C is linked to breast cancer.